A Review on Diversity of Anticancer Compounds Derived from Indonesian Marine Sponges

As a tropical archipelago country, Indonesia has a mega diversity of marine organisms, such as sponges. About 850 species of sponges were identified from the east part of Indonesia. The uniqueness of Indonesian marine sponges attracted many researchers to explore the sponge's potential in producing active substances. During 1995-2016, about 40 genera of Indonesian sponges were investigated for their potential in producing pharmacological activity such as antimicrobial, anticancer, antivirus, multidrug-resistant (MDR), etc. The data showed that 56.7% of 430 reported compounds were confirmed as new compounds. The research trend on Indonesian sponges was high during 2004-2013, but decreasing after 2014. However, researches in the term of active substances from marine sponges should find provide the basic skeleton of anti-cancer drug lead compounds. Chemical structure diversity plays an important role in the exploration of anticancer lead compounds. The purpose of this paper is to review the potential of anticancer diversity compounds derived from Indonesian sponges, to get comprehensive data for further investigation. As the conclusion of our review, the most anticancer compounds derived from Indonesian marine invertebrates are alkaloid groups (such as aaptamine, manzamine, and bromopyrrole derivatives), then terpenoid groups (such as diterpene, coelodiol, and coeloic acid, sesquiterpene aminoquinone, and also (+)-curcuphenol and (+)-curcudiol), and also from the other groups such as sterole, peptide, polyketide, amino acid derivatives, natural organic acid, and quinone. The most effective anticancer compounds were 5-benzoyldemethylaaptamine, isoaaptamine, 3-bromofascaplysin, hyrtioreticulins A, stylissamide X, sigmosceptrellin B, and diacarperoxide S.